Imprivata recorded $76 million in sales during the year ended March 31, 2014, according to NASDAQ. The IPO is expected to give the company a diluted market value of about $387 million.
More Articles on IPOs:
21st Century Oncology Launches IPO
10 Things To Know About Castlight Health’s IPO
IMS Health’s $1.3B IPO Shows Investors Recognize Value of Big Data
